Form 6-K GSK PLC For: Jun 24
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
20,570€
1,58%
Echtzeit-Aktienkurs GSK PLC
Bid:
20,530€
Ask:
20,610€
Nachrichten zur GSK PLC Aktie
GSK and Sanofis Covid-19 Vaccine Could Pose a Challenge to Pfizer and Moderna
Sanofi and GSK's joint Covid-19 vaccine has finally produced data that could challenge the dominance of the Pfizer and Moderna…
Sanofi-GSK legen Ergebnisse zu Impfstoff-Studie unter Omikron vor
PARIS (dpa-AFX) - Das französisch-britische Herstellerduo Sanofi-GSK (GlaxoSmithKline) hat einen Covid-19-Impfstoff eigenen Angaben zufolge erfolgreich gegen eine Omikron-Linie ......…
Sanofi, GSK say their next-generation COVID-19 booster has 72% efficacy against omicron
Sanofi and GlaxoSmithKline said Friday that their experimental bivalent COVID-19 booster had a 72% efficacy rate against omicron,…
GSK-Sanofi Beta-containing vaccine shows efficacy against Omicron
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
UPDATE 1-Sanofi, GSK COVID vaccine found effective against Omicron
...(Adds details, shares)
PARIS, June 24 (Reuters) - Late-stage data......…
BRIEF-GSK Says Sanofi-GSK First To Report Successful Efficacy Study Against Omicron With COVID Beta-Containing Vaccine
...June 24 (Reuters) - GSK plc:
* GSK - SANOFI-GSK FIRST TO REPORT......…
Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial
LONDON (dpa-AFX) - Drug majors Sanofi (SNYNF, SNY) and GSK plc (GSK.L) announced Friday positive data from their vaccine trial…
GSK and Sanofi tout positive vaccine results against Omicron
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi, GSK Report Successful Vaccine Study Against Omicron
Sanofi, GSK Report Successful Vaccine Study Against Omicron...…
Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine...…
Oragenics names former GSK exec Kimberly Murphy as CEO
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
GlaxoSmithKline to invest £1bn in infectious disease R&D
Um den gesamten Artikel unter sharecast.com zu lesen, klicken Sie bitte auf die Überschrift...…
BRIEF-GSK Announces £1 Billion Research And Development Investment
...June 23 (Reuters) - GSK plc:
* GSK - £1 BILLION RESEARCH......…
GSK To Spend 1 Bln Pound Over 10 Years To Fight Infectious Diseases In Lower-income Nations
LONDON (dpa-AFX) - Global healthcare business GSK plc (GSK) on Thursday announced an R&D investment of 1 billion pounds, spanning…
GSK bekämpft mit 1 Mrd Pfund Infektionskrankheiten in armen Ländern
Von Joe Hoppe LONDON (Dow Jones)--Der britische Pharmakonzern GSK will verstärkt gegen Infektionskrankheiten vorgehen, von denen überproportional ärmere Länder…
TOP NEWS: GSK invests GBP1 billion to combat infectious diseases
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
GSK to Invest GBP1 Bln Tackling Infectious Diseases in Low-Income Countries
GSK to Invest GBP1 Bln Tackling Infectious Diseases in Low-Income Countries...…
GSK to invest £1B in R&D to fight infectious diseases in lower-income countries
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
UPDATE 1-GSK, Novartis pledge funds for diseases that mostly affect the poor
... Rigby
LONDON, June 23 (Reuters) - GSK and Novartis
reinforced......…
Investor views on GSK "significantly swing towards positive" ahead of Haleon spin-off
Um den gesamten Artikel unter proactiveinvestors.com zu lesen, klicken Sie bitte auf die Überschrift...…
GSK (GSK) Investing $1.2 Billion in Infectious Diseases
Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…
GSK, Novartis pledge funds for diseases that mostly affect the poor
...By Natalie Grover and Jennifer Rigby
LONDON (Reuters) - GSK......…
GlaxoSmithKline Buy
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für GlaxoSmithKline auf "Buy" mit einem Kursziel von 2100…
GlaxoSmithKline (GSK) Gains As Market Dips: What You Should Know
GlaxoSmithKline (GSK) closed at $41.97 in the latest trading session, marking a +0.48% move from the prior day....…
GlaxoSmithKline needs to be better in pharma arena, suggests Barclays
Um den gesamten Artikel unter proactiveinvestors.com zu lesen, klicken Sie bitte auf die Überschrift...…
GlaxoSmithKline needs to be better in pharrma arena, suggests Barclays
Um den gesamten Artikel unter proactiveinvestors.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Outlook on the Antidepressant Drugs Global Market to 2030 - Featuring Alkermes, AbbVie and GlaxoSmithKline Among Others
DUBLIN, June 17, 2022 /PRNewswire/ -- The "Antidepressant Drugs Market by Product, Depressive Disorder: Global Opportunity Analysis and Industry Forecast,…
What investors need to know as GSK and Pfizer spin off Haleon
Um den gesamten Artikel unter proactiveinvestors.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Spherix Research Reveals Rheumatologists Taking the Lead Over Nephrologists in Both BENLYSTA (GlaxoSmithKline) and LUPKYNIS (Aurinia) Patient Initiations in Lupus Nephritis
Nephrologists and rheumatologists are approaching the new products from very different perspectives EXTON, Pa. , June 17, 2022 /PRNewswire/ --…
GlaxoSmithKline (GSK) Stock Moves -0.74%: What You Should Know
In the latest trading session, GlaxoSmithKline (GSK) closed at $41.64, marking a -0.74% move from the previous day....…
Form 6-K GSK PLC For: Jun 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
GlaxoSmithKline (GSK) Outpaces Stock Market Gains: What You Should Know
GlaxoSmithKline (GSK) closed at $41.95 in the latest trading session, marking a +1.72% move from the prior day....…
BRIEF-FTSE Russell Says Haleon Will Be Added To All Same Indices As GSK On July 18
...June 15 (Reuters) - FTSE Russell:
* FTSE RUSSELL - ON 18 JULY, HALEON......…
Ascential Digital Commerce und GSK Consumer Healthcare geben die Einführung von Ascential Digital Commerce Connect auf dem Cannes Lions bekannt
LONDON--(BUSINESS WIRE)--Ascential Digital Commerce, mit dessen technologiebasierten Produkten Marken im digitalen Handel erfolgreich sein können, und GSK Consumer Healthcare, ein…
After its £2.4bn demerger, can the GSK share price blossom?
What could becoming a standalone biotech stock mean for the GSK share price? Will it continue to tread water or…
COVID-variant booster from Sanofi, GSK shows promising results
A COVID-19 vaccine developed by Sanofi SA and GSK PLC to target the Beta strain of the virus produced a stronger antibody response against…
Sanofi (SNY), GSK COVID Booster Jab Effective Against Omicron
Data from clinical studies show that Sanofi (SNY) and Glaxos (GSK) next-generation COVID-19 booster candidate elicits a stronger immune response…
Booster mit starker Immunantwort: Sanofi/GSK wollen wieder ins Corona-Impfrennen eingreifen
Die EU hat bestellt - doch die französische-britische Kooperation von Sanofi und GlaxoSmithKline kann bislang kein zugelassenes Corona-Vakzin vorweisen. Nun…
Covid-19 Variant Shot From Sanofi, GSK Shows Strong Response to Omicron
Results from two new studies are the latest indication that tweaking vaccines can nudge antibody responses in the direction of…
Sanofi-GSK COVID booster outperforms Pfizer/BioNTech vaccine against Omicron
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
GlaxoSmithKline Hold
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für GlaxoSmithKline auf "Hold" mit einem Kursziel von 1750…
TOP NEWS: Sanofi, GSK booster jab impresses against Omicron
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi, GSK Say Their Covid Booster Works Better Against Omicron
Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi-GSK Next-gen COVID-19 Booster Induces Strong Immune Response Against Variants Of Concern
PARIS (dpa-AFX) - Sanofi (SNYNF)m on Monday said data from the Phase 3 VAT02 Cohort 2 study showed that its…
Sanofi-GSK Covid-19 Booster Showing Strong Immune Response, Sanofi Says
Sanofi-GSK Covid-19 Booster Showing Strong Immune Response, Sanofi Says...…
Press Release: Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron
Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron...…
Shot in the arm for Glaxo after respiratory jab breakthrough
Glaxo giant said its jab showed statistically significant and clinically meaningful effectiveness in a major trial....…
A Potential GSK Game Changer And An MRNA Cancer Vaccine: Highlights From The 2022 ASCO Conference
Big pharmaceutical companies reported steady improvements on cancer treatments....…
GSK Reports a Win for Its RSV Vaccine
There are currently no RSV vaccines approved in the U.S. Approval for its RSV vaccine could mark a big win…